Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1.

OBJECTIVE To determine whether articular chondrocytes express growth factor genes delivered by adenoviral vectors and whether expression of these genes influences matrix synthesis in the presence and absence of interleukin-1 (IL-1). METHODS Monolayer cultures of rabbit articular chondrocytes were infected with recombinant adenovirus carrying genes encoding the following growth factors: insulin-like growth factor 1 (IGF-1), transforming growth factor beta1 (TGFbeta1), and bone morphogenetic protein 2 (BMP-2). As a control, cells were transduced with the lac Z gene. Cultures were also treated with each growth factor supplied as a protein. Levels of gene expression were noted, and the synthesis of proteoglycan, collagen, and noncollagenous proteins was measured by radiolabeling. Collagen was typed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. The effects of growth factor gene transfer on proteoglycan synthesis in the presence of IL-1 were also measured. RESULTS The expression of all transgenes was high following adenoviral transduction. Proteoglycan synthesis was stimulated approximately 8-fold by the BMP-2 gene and 2-3-fold by the IGF-1 gene. The effects of BMP-2 and IGF-1 genes were additive upon cotransduction. Synthesis of collagen and noncollagenous proteins, in contrast, was most strongly stimulated by the IGF-1 gene. In each case, collagen typing confirmed the synthesis of type II collagen. IL-1 suppressed proteoglycan synthesis by 50-60%. IGF-1 and TGFbeta genes restored proteoglycan synthesis to control levels in the presence of IL-1. The BMP-2 gene, in contrast, elevated proteoglycan synthesis beyond control levels in the presence of IL-1. CONCLUSION Transfer of growth factor genes to articular chondrocytes can greatly increase matrix synthesis in vitro, even in the presence of the inflammatory cytokine IL-1. This result encourages the further development of gene therapy for the repair of damaged cartilage.

[1]  E. Thonar,et al.  Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. , 1996, Arthritis and rheumatism.

[2]  K. Matsumoto,et al.  Hepatocyte growth factor facilitates cartilage repair. Full thickness articular cartilage defect studied in rabbit knees. , 1997, Acta orthopaedica Scandinavica.

[3]  C. Archer,et al.  The reactions of articular cartilage to experimental wounding: role of apoptosis. , 2000, Arthritis and rheumatism.

[4]  H J Mankin,et al.  Articular cartilage repair and transplantation. , 1998, Arthritis and rheumatism.

[5]  S. Efstathiou,et al.  High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cells , 1998, Gene Therapy.

[6]  G. Meachim,et al.  Repair of the joint surface from subarticular tissue in the rabbit knee. , 1971, Journal of anatomy.

[7]  I. Kovesdi,et al.  Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression , 1997, Journal of virology.

[8]  J. Tyler.  Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. , 1985, The Biochemical journal.

[9]  F. Lafeber,et al.  Osteoarthritic human cartilage is more sensitive to transforming growth factor beta than is normal cartilage. , 1993, British journal of rheumatology.

[10]  T. I. Morales.  Transforming growth factor-beta 1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. , 1991, Archives of biochemistry and biophysics.

[11]  C. Evans,et al.  Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. , 1994, Biochemical and biophysical research communications.

[12]  P. Robbins,et al.  Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. , 1997, Osteoarthritis and cartilage.

[13]  Y. Kaneda,et al.  In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. , 1997, Arthritis and rheumatism.

[14]  W. B. van den Berg,et al.  Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1alpha effects on proteoglycan synthesis and content. , 1997, Arthritis and rheumatism.

[15]  P. Hebda,et al.  Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. , 1997, The Biochemical journal.

[16]  C. Evans,et al.  Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis. , 1999, Arthritis and rheumatism.

[17]  W. T. Green,et al.  Behavior of articular chondrocytes in cell culture. , 1971, Clinical orthopaedics and related research.

[18]  J. Buckwalter,et al.  Age‐related decline in chondrocyte response to insulin‐like growth factor‐I: The role of growth factor binding proteins , 1997, Journal of Orthopaedic Research.

[19]  F. Lafeber,et al.  Transforming growth factor-beta predominantly stimulates phenotypically changed chondrocytes in osteoarthritic human cartilage. , 1997, The Journal of rheumatology.

[20]  F. Blanco,et al.  Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. , 1998, Arthritis and rheumatism.

[21]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[22]  K. Takeshita,et al.  Adenovirus vector-mediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-beta 1 and heat shock protein 70 gene transduction. , 1997, The Journal of rheumatology.

[23]  W. B. van den Berg,et al.  Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation. , 1998, Arthritis and rheumatism.

[24]  S. Abramson,et al.  Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. , 1997, Osteoarthritis and cartilage.

[25]  M. Kitamura,et al.  Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.

[26]  C. Evans,et al.  Nitric oxide and proteoglycan turnover in rabbit articular cartilage , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  E. Thonar,et al.  Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin‐1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin‐1β , 1997 .

[28]  S. O’Driscoll.  Current Concepts Review - The Healing and Regeneration of Articular Cartilage* , 1998 .

[29]  P. Robbins,et al.  Genetically augmented tissue engineering of the musculoskeletal system. , 1999, Clinical orthopaedics and related research.

[30]  J. Tyler.  Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. , 1989, The Biochemical journal.

[31]  G. Meachim.  THE EFFECT OF SCARIFICATION ON ARTICULAR CARTILAGE IN THE RABBIT , 1963 .

[32]  J. Pelletier,et al.  Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. , 1994, Arthritis and rheumatism.

[33]  P. Robbins,et al.  Increased matrix synthesis following adenoviral transfer of a transforming growth factor β1 gene into articular chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[34]  D. Grande,et al.  Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair , 1998, Gene Therapy.

[35]  A. Reddi,et al.  Role of morphogenetic proteins in skeletal tissue engineering and regeneration , 1998, Nature Biotechnology.

[36]  E. Morris,et al.  The Effect of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) on the Healing of Full-Thickness Defects of Articular Cartilage* , 1997, The Journal of bone and joint surgery. American volume.

[37]  S. Scully,et al.  Extracellular collagen modulates the regulation of chondrocytes by transforming growth factor‐β1 , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[38]  P. Robbins,et al.  Possible orthopaedic applications of gene therapy. , 1995, The Journal of bone and joint surgery. American volume.

[39]  S. Trippel.  Growth factor actions on articular cartilage. , 1995, The Journal of rheumatology. Supplement.